Chiesi drug scores approval for rare disease

Chiesi Farmaceutici S.p.A. (Parma, Italy) said the European Commission approved an MAA for Lamzede velmanase alfa to treat non-neurological manifestations in patients with mild to moderate alpha-mannosidosis, a rare lysosomal storage disease...